Hydroxyurea Dose Escalation Effective for Children with Sickle Cell Anemia
Extended follow-up of an open-label, phase 1/2 trial revealed an escalation of hydroxyurea to the maximum tolerated dose (MTD) significantly improved clinical response and treatment outcomes, without increasing toxicities, in children with sickle cell …